Holen Sie sich die Stockscreener-App
8.72
1.28%
0.11
Handel nachbörslich:
8.65
-0.07
-0.80%
Schlusskurs vom Vortag:
$8.61
Offen:
$8.66
24-Stunden-Volumen:
86,042
Relative Volume:
0.87
Marktkapitalisierung:
$180.90M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+6.08%
1M Leistung:
+23.34%
6M Leistung:
+24.22%
1J Leistung:
+6.41%
1-Tages-Spanne:
$8.55
$9.22
1-Wochen-Bereich:
$8.02
$9.22
52-Wochen-Spanne:
$5.47
$11.99
Actuate Therapeutics Inc Stock (ACTU) Company Profile
Firmenname
Actuate Therapeutics Inc
Sektor
Branche
Telefon
847-986-4190
Adresse
1751 RIVER RUN, FORT WORTH
Vergleichen Sie ACTU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACTU
Actuate Therapeutics Inc
|
8.72 | 180.48M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Actuate Therapeutics Inc Stock (ACTU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-26 | Eingeleitet | B. Riley Securities | Buy |
| 2025-04-22 | Eingeleitet | Craig Hallum | Buy |
| 2025-03-17 | Eingeleitet | H.C. Wainwright | Buy |
Actuate Therapeutics Inc Aktie (ACTU) Neueste Nachrichten
What data driven models say about Actuate Therapeutics Inc.’s futureWeekly Investment Report & Entry Point Strategy Guides - Newser
Real time social sentiment graph for Actuate Therapeutics Inc.New Guidance & Verified Momentum Stock Watchlist - Newser
Will Actuate Therapeutics Inc. stock go up soonPrice Action & AI Driven Stock Movement Reports - Newser
Leading vs lagging indicators on Actuate Therapeutics Inc. performanceAnalyst Downgrade & Consistent Return Strategy Ideas - Newser
Can Actuate Therapeutics Inc. recover in the next quarterWeekly Earnings Recap & Stepwise Swing Trade Plans - Newser
Forecasting Actuate Therapeutics Inc. price range with options data2025 Retail Activity & Low Risk Entry Point Tips - Newser
Using economic indicators to assess Actuate Therapeutics Inc. potentialJuly 2025 Selloffs & Safe Entry Momentum Tips - Newser
How to read the order book for Actuate Therapeutics Inc.Gap Up & Consistent Profit Focused Trading Strategies - Newser
Regression analysis insights on Actuate Therapeutics Inc. performance2025 Historical Comparison & Reliable Intraday Trade Plans - Newser
Chart overlay techniques for tracking Actuate Therapeutics Inc.Weekly Trend Report & Low Risk High Reward Trade Ideas - Newser
Is Actuate Therapeutics Inc. impacted by rising ratesEarnings Performance Report & Trade Opportunity Analysis - khodrobank.com
Has Actuate Therapeutics Inc. formed a bullish divergence2025 Top Decliners & Proven Capital Preservation Methods - Newser
Exit strategy if you’re trapped in Actuate Therapeutics Inc.July 2025 Selloffs & Technical Confirmation Trade Alerts - Newser
Is Actuate Therapeutics Inc. still worth holding after the dipSell Signal & Daily Growth Stock Investment Tips - Newser
Predicting Actuate Therapeutics Inc. trend using moving averagesJuly 2025 Selloffs & Verified Momentum Stock Ideas - Newser
Actuate Therapeutics files $250M mixed securities shelf - MSN
How to track smart money flows in Actuate Therapeutics Inc.Weekly Loss Report & Accurate Technical Buy Alerts - Newser
Combining price and volume data for Actuate Therapeutics Inc.Earnings Miss & Daily Technical Stock Forecast Reports - Newser
Combining machine learning predictions for Actuate Therapeutics Inc.2025 Key Highlights & Capital Protection Trading Alerts - Newser
What technical models suggest about Actuate Therapeutics Inc.’s comebackJuly 2025 Action & Long-Term Growth Stock Strategies - Newser
When is the best time to exit Actuate Therapeutics Inc.Earnings Summary Report & Weekly Top Gainers Alerts - Newser
Should I set a stop loss on Actuate Therapeutics Inc.Trade Entry Report & Technical Entry and Exit Alerts - khodrobank.com
Can a trend reversal in Actuate Therapeutics Inc. lead to recoveryStock Surge & Risk Managed Investment Strategies - Newser
Can Actuate Therapeutics Inc. lead its sector in growthOil Prices & Safe Capital Growth Stock Tips - خودرو بانک
Is Actuate Therapeutics Inc. forming a bottoming baseWeekly Risk Summary & Weekly Market Pulse Alerts - Newser
Actuate Therapeutics Inc. Facing Inflection Point in Trend Analysis getLinesFromResByArray error: size == 0 - kangso.co.kr
Published on: 2025-09-01 18:50:37 - khodrobank.com
Published on: 2025-08-31 16:14:11 - Newser
Will Actuate Therapeutics Inc. stock split in the near futureTrend Reversal & Reliable Entry Point Alerts - Newser
Is a relief rally coming for Actuate Therapeutics Inc. holders2025 Market Outlook & Smart Swing Trading Alerts - Newser
Has Actuate Therapeutics Inc. found a price floorJuly 2025 Price Swings & Capital Efficient Trade Techniques - Newser
Finanzdaten der Actuate Therapeutics Inc-Aktie (ACTU)
Es liegen keine Finanzdaten für Actuate Therapeutics Inc (ACTU) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Actuate Therapeutics Inc-Aktie (ACTU) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kreis Leslie W. | Director |
Jun 27 '25 |
Buy |
7.00 |
71,428 |
499,996 |
196,428 |
| Fletcher Aaron G.L. | Director |
Jun 27 '25 |
Buy |
7.00 |
71,428 |
499,996 |
196,428 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):